A detailed history of Smith Chas P & Associates Pa Cpas transactions in Pfizer Inc stock. As of the latest transaction made, Smith Chas P & Associates Pa Cpas holds 78,089 shares of PFE stock, worth $2.17 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
78,089
Previous 90,341 13.56%
Holding current value
$2.17 Million
Previous $2.6 Million 16.72%
% of portfolio
0.13%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$25.89 - $29.73 $317,204 - $364,251
-12,252 Reduced 13.56%
78,089 $2.17 Million
Q4 2023

Feb 01, 2024

SELL
$26.13 - $33.94 $498,900 - $648,016
-19,093 Reduced 17.45%
90,341 $2.6 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $771,411 - $901,702
-24,039 Reduced 18.01%
109,434 $3.63 Million
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $21.5 Million - $24.8 Million
-594,461 Reduced 81.66%
133,473 $4.9 Million
Q1 2023

Apr 27, 2023

BUY
$39.39 - $51.28 $319,374 - $415,778
8,108 Added 1.13%
727,934 $29.7 Million
Q4 2022

Jan 12, 2023

BUY
$41.75 - $54.5 $192,968 - $251,899
4,622 Added 0.65%
719,826 $36.9 Million
Q3 2022

Nov 22, 2022

BUY
$43.76 - $53.42 $199,108 - $243,061
4,550 Added 0.64%
715,204 $31.3 Million
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $295,605 - $350,495
6,353 Added 0.9%
710,654 $37.3 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $69,723 - $86,395
-1,524 Reduced 0.22%
704,301 $36.5 Million
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $333,576 - $494,471
-8,073 Reduced 1.13%
705,825 $41.7 Million
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $695,117 - $892,938
17,710 Added 2.54%
713,898 $30.7 Million
Q2 2021

Jul 23, 2021

BUY
$35.91 - $40.68 $609,033 - $689,932
16,960 Added 2.5%
696,188 $27.3 Million
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $983,232 - $1.11 Million
29,359 Added 4.52%
679,228 $24.6 Million
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $497,665 - $632,824
14,869 Added 2.34%
649,869 $23.9 Million
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $136,620 - $160,286
-4,303 Reduced 0.67%
635,000 $23.3 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $80,571 - $97,744
-2,675 Reduced 0.42%
639,303 $20.9 Million
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $409,017 - $584,397
15,132 Added 2.41%
641,978 $21 Million
Q4 2019

Feb 04, 2020

BUY
$32.92 - $37.36 $65,872 - $74,757
2,001 Added 0.32%
626,846 $24.6 Million
Q3 2019

Nov 06, 2019

SELL
$32.49 - $42.13 $81,744 - $105,999
-2,516 Reduced 0.4%
624,845 $22.5 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $655,174 - $735,609
-17,717 Reduced 2.75%
627,361 $27.2 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $504,300 - $554,057
-13,448 Reduced 2.04%
645,078 $27.4 Million
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $796,136 - $907,682
-20,695 Reduced 3.05%
658,526 $28.7 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $229,949 - $278,914
-6,671 Reduced 0.97%
679,221 $29.9 Million
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $343,453 - $366,156
10,414 Added 1.54%
685,892 $24.9 Million
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $366,805 - $425,544
11,495 Added 1.73%
675,478 $24 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $560,630 - $594,848
16,856 Added 2.6%
663,983 $24 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $20.1 Million - $22.1 Million
647,127
647,127 $23.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Smith Chas P & Associates Pa Cpas Portfolio

Follow Smith Chas P & Associates Pa Cpas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Chas P & Associates Pa Cpas, based on Form 13F filings with the SEC.

News

Stay updated on Smith Chas P & Associates Pa Cpas with notifications on news.